Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

Peter G. Miller, Dandi Qiao, Joselyn Rojas-Quintero, Michael C. Honigberg, Adam S. Sperling, Christopher J. Gibson, Alexander G. Bick, Abhishek Niroula, Marie E. McConkey, Brittany Sandoval, Brian C. Miller, Weiwei Shi, Kaushik Viswanathan, Matthew Leventhal, Lillian Werner, Matthew Moll, Brian E. Cade, R. Graham Barr, Adolfo Correa, L. Adrienne Cupples, Sina A. Gharib, Deepti Jain, Stephanie M. Gogarten, Leslie A. Lange, Stephanie J. London, Ani Manichaikul, George T. O’Connor, Elizabeth C. Oelsner, Susan Redline, Stephen S. Rich, Jerome I. Rotter, Vasan Ramachandran, Bing Yu, Lynette Sholl, Donna Neuberg, Siddhartha Jaiswal, Bruce D. Levy, Caroline A. Owen, Pradeep Natarajan, Edwin K. Silverman, Peter van Galen, Yohannes Tesfaigzi, Michael H. Cho, Benjamin L. Ebert, for the COPDGene Study Investigators, National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine Consortium

Blood (2022) 139 (3): 357–368.

https://doi.org/10.1182/blood.2021013531

Published: 2022

Includes: Supplemental data

Journal Articles

Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Naïve Patients with Relapsed or Refractory Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Multi-Center Phase 1, Two-Arm, Dose-Escalation Study

Blood (2019) 134 (Supplement_1): 2015.

https://doi.org/10.1182/blood-2019-126238

Published: 2019

Journal Articles

T Cell Determinants of Response and Resistance to PD-1 Blockade in Richter's Transformation

Blood (2019) 134 (Supplement_1): 680.

https://doi.org/10.1182/blood-2019-125904

Published: 2019

Journal Articles

Phase I Trial of Escalating Doses of the Bcl-2 Inhibitor Venetoclax in Combination with Daunorubicin/Cytarabine Induction and High Dose Cytarabine Consolidation in Previously Untreated Adults with Acute Myeloid Leukemia ( AML)

Richard M. Stone, MD, Daniel J. DeAngelo, MD PhD, Ilene Galinsky, Caroline Kokulis, Jeremy M. Stewart, BA, Michael McGinnis, Lillian Werner, MS, Anthony G. Letai, MD PhD, Marina Y Konopleva, MD PhD, Marlise Luskin, MDMS

Blood (2019) 134 (Supplement_1): 3908.

https://doi.org/10.1182/blood-2019-124966

Published: 2019

Journal Articles

Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

Blood (2019) 134 (Supplement_1): 4202.

https://doi.org/10.1182/blood-2019-126164

Published: 2019

Journal Articles

Rate of Differentiation Syndrome in Patients Based on Timing of Initial All-Trans Retinoic Acid Administration

Mary Nauffal, PharmD,MS, Lillian Werner, MS, Anne M. McDonnell, PharmD, BCOP, Jian Ni, PharmD, BCOP, Richard M. Stone, MD, Daniel J. DeAngelo, MD

Blood (2017) 130 (Supplement 1): 2592.

https://doi.org/10.1182/blood.V130.Suppl_1.2592.2592

Published: 2017

Journal Articles

Splicing Modulation Perturbs Key Survival Pathways and Sensitizes Chronic Lymphocytic Leukemia to Venetoclax Treatment

Blood (2017) 130 (Supplement 1): 264.

https://doi.org/10.1182/blood.V130.Suppl_1.264.264

Published: 2017

Journal Articles

Increased Incidence of Philadelphia Negative B-Cell Acute Lymphoblastic Leukemia Among Adults of Hispanic Ethnicity: A Population Based Study

Ashley M. Perry, BS, Evan C. Chen, MD, Marla M. Jalbut, MD, Lillian Werner, MS, Gabriela S. Hobbs, MD, Philip C. Amrein, MD, Amir T. Fathi, MD MD BS, Andrew M. Brunner, MD

Blood (2017) 130 (Supplement 1): 2570.

https://doi.org/10.1182/blood.V130.Suppl_1.2570.2570

Published: 2017

Journal Articles

Phase I/Ib Trial of the MUC1 Inhibitor GO-203-2C Alone and in Combination with Decitabine for Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 2659.

https://doi.org/10.1182/blood.V130.Suppl_1.2659.2659

Published: 2017

Journal Articles

The Impact of Antimicrobial Prophylaxis during Induction Chemotherapy for Acute Myeloid Leukemia in the Current Era

Marla M. Jalbut, MD, Evan C. Chen, MD, Gabriela S. Hobbs, MD, Ashley M. Perry, BS, Lillian Werner, MS, Philip C. Amrein, MD, Amir T. Fathi, MD MD BS, Andrew M. Brunner, MD

Blood (2017) 130 (Supplement 1): 2586.

https://doi.org/10.1182/blood.V130.Suppl_1.2586.2586

Published: 2017

Journal Articles

Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma

Blood (2016) 128 (22): 4052.

https://doi.org/10.1182/blood.V128.22.4052.4052

Published: 2016

Journal Articles

A Phase 1 Study of Lenalidomide in Combination with Mitoxantrone, Etoposide, and Ara-C in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Daniel J. DeAngelo, MD PhD, Amir T. Fathi, MD, Lillian Werner, David Avigan, MD, Katarina Luptakova, MD, Martha Wadleigh, MD, David P. Steensma, MD, Gabriela Soriano Hobbs, MD, Eyal C. Attar, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Karen K. Ballen, MD

Blood (2015) 126 (23): 2550.

https://doi.org/10.1182/blood.V126.23.2550.2550

Published: 2015

Journal Articles

Addition of Rituximab Abrogates Ibrutinib-Induced Lymphocytosis and Promotes More Rapid Decrease in Absolute Lymphocyte Counts in Patients with Relapsed Chronic Lymphocytic Leukemia

Ekaterina Kim, MS, Lillian Werner, Michael J Keating, MBBS, William G. Wierda, MD PhD, Alessandra Ferrajoli, MD, Zeev Estrov, MD, Gracy Zacharian, Thomas J. Kipps, MD, Hagop M. Kantarjian, MD, Donna Neuberg, ScD, Susan O'Brien, MD, Jan A. Burger, MD PhD

Blood (2014) 124 (21): 1998.

https://doi.org/10.1182/blood.V124.21.1998.1998

Published: 2014

Journal Articles

Dynamics Changes in CCL3 and CCL4 Plasma Chemokine Levels in Patients with Chronic Lymhocytic Leukemia (CLL) Managed with Observation

Mariela Sivina, PhD, Lillian Werner, Laura Rassenti, PhD, William G. Wierda, MD PhD, Michael J. Keating, MD, Susan O'Brien, MD, Donna Neuberg, ScD, Thomas J. Kipps, MD PhD, Jan A. Burger, MD PhD

Blood (2014) 124 (21): 5640.

https://doi.org/10.1182/blood.V124.21.5640.5640

Published: 2014

Journal Articles

Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations

John C. Riches, Conor J. O’Donovan, Sarah J. Kingdon, Fabienne McClanahan, Andrew J. Clear, Donna S. Neuberg, Lillian Werner, Carlo M. Croce, Alan G. Ramsay, Laura Z. Rassenti, Thomas J. Kipps, John G. Gribben

Blood (2014) 123 (26): 4101–4110.

https://doi.org/10.1182/blood-2014-01-552307

Published: 2014

Includes: Supplemental data

Journal Articles

Inhibition Of Lyn and Syk By Treatment With Dasatinib, Fludarabine, and Rituximab Correlates With Apoptosis and Clinical Response In Patients With Relapsed CLL

Philip C. Amrein, MD, Xin Kai, Carlos Donato, Jon Arnason, MD, Jennifer R. Brown, M.D., Karen K. Ballen, MD, Eyal C. Attar, MD, Amir T. Fathi, MD, Ephraim P Hochberg, MD, HyukJoo Hwang, Lillian Werner, Donna Neuberg, ScD, Shiv Pillai, MD, PhD

Blood (2013) 122 (21): 5300.

https://doi.org/10.1182/blood.V122.21.5300.5300

Published: 2013

Journal Articles

NF-κB Pathway Mutations Modulate Cell Survival and Ibrutinib Response In Chronic Lymphocytic Leukemia

Reina Improgo, Grace Tiao, Adam Kiezun, Yaoyu Wang, Lillian Werner, Carrie Sougnez, Bethany Tesar, Stacey M Fernandes, Alexander R. Vartanov, Kevin Hoang, Donna S. Neuberg, ScD, Gad Getz, Jennifer R. Brown, M.D.

Blood (2013) 122 (21): 670.

https://doi.org/10.1182/blood.V122.21.670.670

Published: 2013

Journal Articles

Effect Of MYD88 Mutation In CLL On IRAK4 and BTK Inhibition In Vitro

Bethany Tesar, Divya Chaudhary, Lillian Werner, Reina Improgo, Nathalie Pochet, Stacey M Fernandes, Kevin Hoang, Alexander R. Vartanov, Donna L. Romero, Shaughnessy D. Robinson, Donna S. Neuberg, ScD, William F. Westlin, Jennifer R. Brown, M.D.

Blood (2013) 122 (21): 4132.

https://doi.org/10.1182/blood.V122.21.4132.4132

Published: 2013

Journal Articles

Risk Alleles Identified in Genome-Wide Association Studies Are Associated with Expression Quantitative Trait Loci in Chronic Lymphocytic Leukemia.

Bethany Tesar, Lillian Werner, Megan Hanna, Ma Reina Improgo, Nathalie Pochet, Stacey M. Fernandes, Laura Macconaill, Ph.D., Aviv Regev, PhD, Arnold S. Freedman, M.D., Donna S. Neuberg, ScD, Matthew L. Freedman, M.D., Jennifer R. Brown, MD, PhD

Blood (2012) 120 (21): 2875.

https://doi.org/10.1182/blood.V120.21.2875.2875

Published: 2012

Journal Articles

Functional Somatic and Germline Variants in the NF-κB Pathway in Chronic Lymphocytic Leukemia

Ma. Reina Improgo, Adam Kiezun, Yaoyu Wang, Lillian Werner, Petar Stojanov, Dan Landau, M.D., Carrie Sougnez, Bethany Tesar, Stacey M. Fernandes, Alexander R. Vartanov, BS, Michael S. Lawrence, Kristian Cibulskis, Donna S. Neuberg, ScD, Catherine J. Wu, MD, Gad Getz, Ph.D., Jennifer R. Brown, MD, PhD

Blood (2012) 120 (21): 560.

https://doi.org/10.1182/blood.V120.21.560.560

Published: 2012

NARROW

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Naïve Patients with Relapsed or Refractory Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Multi-Center Phase 1, Two-Arm, Dose-Escalation Study

T Cell Determinants of Response and Resistance to PD-1 Blockade in Richter's Transformation

Phase I Trial of Escalating Doses of the Bcl-2 Inhibitor Venetoclax in Combination with Daunorubicin/Cytarabine Induction and High Dose Cytarabine Consolidation in Previously Untreated Adults with Acute Myeloid Leukemia ( AML)

Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

Rate of Differentiation Syndrome in Patients Based on Timing of Initial All-Trans Retinoic Acid Administration

Splicing Modulation Perturbs Key Survival Pathways and Sensitizes Chronic Lymphocytic Leukemia to Venetoclax Treatment

Increased Incidence of Philadelphia Negative B-Cell Acute Lymphoblastic Leukemia Among Adults of Hispanic Ethnicity: A Population Based Study

Phase I/Ib Trial of the MUC1 Inhibitor GO-203-2C Alone and in Combination with Decitabine for Acute Myeloid Leukemia

The Impact of Antimicrobial Prophylaxis during Induction Chemotherapy for Acute Myeloid Leukemia in the Current Era

Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma

A Phase 1 Study of Lenalidomide in Combination with Mitoxantrone, Etoposide, and Ara-C in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Addition of Rituximab Abrogates Ibrutinib-Induced Lymphocytosis and Promotes More Rapid Decrease in Absolute Lymphocyte Counts in Patients with Relapsed Chronic Lymphocytic Leukemia

Dynamics Changes in CCL3 and CCL4 Plasma Chemokine Levels in Patients with Chronic Lymhocytic Leukemia (CLL) Managed with Observation

Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations

Inhibition Of Lyn and Syk By Treatment With Dasatinib, Fludarabine, and Rituximab Correlates With Apoptosis and Clinical Response In Patients With Relapsed CLL

NF-κB Pathway Mutations Modulate Cell Survival and Ibrutinib Response In Chronic Lymphocytic Leukemia

Effect Of MYD88 Mutation In CLL On IRAK4 and BTK Inhibition In Vitro

Risk Alleles Identified in Genome-Wide Association Studies Are Associated with Expression Quantitative Trait Loci in Chronic Lymphocytic Leukemia.

Functional Somatic and Germline Variants in the NF-κB Pathway in Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only